Harrow Health Inc Stock, NASDAQ:HROW
102 Woodmont Boulevard, Suite 610, Nashville, Tennessee 37205
United States of America
Number of Employees: 125
Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments. The Pharmaceutical Compounding segment focuses on the operations of ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.